A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients
Clinical trial NCT04869228 · TERMINATED
Trial details
- NCT number
- NCT04869228
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-04
- Primary completion
- 2022-09-02
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.